<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Due to the risk of vascular complications, the indication for heart transplantation (HTx) in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and <z:e sem="disease" ids="C0919984" disease_type="Disease or Syndrome" abbrv="">end-stage heart disease</z:e> remains controversial </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed the results of such patients who underwent HTx at our institution </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Ten patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (median age 36, range 19 to 56 years) underwent HTx between March 1986 and December 2005 </plain></SENT>
<SENT sid="3" pm="."><plain>The primary vascular manifestation of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> was type-A <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> in three patients and <z:hpo ids='HP_0002631'>ascending aortic aneurysm</z:hpo> in seven patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had undergone cardiovascular operations prior to transplantation </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had refractory <z:hpo ids='HP_0001635'>heart failure</z:hpo> (New York Heart Association class IV) before transplantation </plain></SENT>
<SENT sid="6" pm="."><plain>Three patients underwent transplantation after ventricular assist device (VAD) support (left VAD, n = 2; biventricular assist device, n = 1) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: There were no perioperative <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Two patients died of causes unrelated to Marfan disease (<z:hpo ids='HP_0002090'>pneumonia</z:hpo> on day 27, n = 1; <z:hpo ids='HP_0001297'>stroke</z:hpo> on day 102, n = 1) </plain></SENT>
<SENT sid="9" pm="."><plain>One patient died due to type-B dissection 3.8 years posttransplantation and one due to rupture of an aortic arch <z:hpo ids='HP_0002617'>aneurysm</z:hpo> after 12.1 years </plain></SENT>
<SENT sid="10" pm="."><plain>Two patients underwent thoracoabdominal aortic replacement for <z:hpo ids='HP_0011010'>chronic</z:hpo> dissection 14 and 20 months posttransplantation, respectively </plain></SENT>
<SENT sid="11" pm="."><plain>Kaplan-Meier survival rate was 80% at 1 year and 64% at 10 years </plain></SENT>
<SENT sid="12" pm="."><plain>The Kaplan-Meier freedom from reoperation was 100% at 1 year and 62.5% at 10 years </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Heart transplantation in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> results in good long-term survival, similar to that of patients without <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>Close follow-up and timely operation of aortic pathologies is mandatory </plain></SENT>
<SENT sid="15" pm="."><plain>Reluctance to place these patients on a heart transplant waiting list appears not to be justified </plain></SENT>
</text></document>